Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 54

    1.

    Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C.

    Floreani A, Antoniazzi S, Mescoli C, Bergasa NV.

    Eur J Gastroenterol Hepatol. 2012 Apr;24(4):427-30.

    PMID:
    22293330
    [PubMed - indexed for MEDLINE]
    2.

    Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.

    Wu DL, Xu GH, Lu SM, Ma BL, Miao NZ, Liu XB, Feng JH, Liu N, Zeng QL, Hou WK, Pei L, Zhao Y.

    Eur J Gastroenterol Hepatol. 2012 Apr;24(4):406-13.

    PMID:
    22273989
    [PubMed - indexed for MEDLINE]
    3.

    Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.

    Arai M, Togo S, Kanda T, Fujiwara K, Imazeki F, Yokosuka O.

    Eur J Gastroenterol Hepatol. 2012 Apr;24(4):414-8.

    PMID:
    22273987
    [PubMed - indexed for MEDLINE]
    4.

    Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both?

    Welte S, Gagesch M, Weber A, Longerich T, Millonig G.

    Eur J Gastroenterol Hepatol. 2012 Mar;24(3):328-31.

    PMID:
    22228371
    [PubMed - indexed for MEDLINE]
    5.

    Absolute CD4 counts in monoinfected chronic hepatitis B patients in the advanced immune-active stage.

    Goswami RP, Goswami RP, Ray Y, Rahman M.

    Eur J Gastroenterol Hepatol. 2012 Feb;24(2):214-5. No abstract available.

    PMID:
    22138686
    [PubMed - indexed for MEDLINE]
    6.

    The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy.

    Lin YM, Sheu MJ, Kuo HT, Feng IC, Sun CS, Koay LB, Lin CY.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):990-6.

    PMID:
    21975695
    [PubMed - indexed for MEDLINE]
    7.

    Additive effect of folic acid deficiency on pegylated interferon's bone marrow toxicity.

    Bugdaci MS, Sokmen M, Toptas T.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):1079-80. No abstract available.

    PMID:
    21971342
    [PubMed - indexed for MEDLINE]
    8.

    Protein energy malnutrition predicts complications in liver cirrhosis.

    Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):982-9.

    PMID:
    21971339
    [PubMed - indexed for MEDLINE]
    9.

    Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.

    Boursier J, Chaigneau J, Roullier V, Lainé F, Sandrini J, Michalak S, Hubert I, Dib N, Oberti F, Bertrais S, Hunault G, Deugnier Y, Rousselet MC, Cavaro-Ménard C, Gallois Y, Aubé C, Calès P; Study group UNAM-METABOL.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):974-81.

    PMID:
    21904208
    [PubMed - indexed for MEDLINE]
    10.

    A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C.

    Sartori M, Andorno S, Rossini A, Boldorini R, Bozzola C, Carmagnola S, Del Piano M, Albano E.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1178-84.

    PMID:
    22002003
    [PubMed - indexed for MEDLINE]
    11.

    Prevalence and risk factors of HCV infection in Poland.

    Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1213-7.

    PMID:
    22002000
    [PubMed - indexed for MEDLINE]
    12.

    A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.

    Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A.

    Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5.

    PMID:
    21900787
    [PubMed - indexed for MEDLINE]
    13.

    The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.

    Yu JW, Sun LJ, Zhao YH, Kang P, Yan BZ.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1192-9.

    PMID:
    21971375
    [PubMed - indexed for MEDLINE]
    14.

    Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.

    Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M.

    Eur J Gastroenterol Hepatol. 2011 Oct;23(10):936-41.

    PMID:
    21900788
    [PubMed - indexed for MEDLINE]
    15.

    Host risk factors and autochthonous hepatitis E infection.

    Dalton HR, Bendall RP, Rashid M, Ellis V, Ali R, Ramnarace R, Stableforth W, Headdon W, Abbott R, McLaughlin C, Froment E, Hall KJ, Michell NP, Thatcher P, Henley WE.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1200-5.

    PMID:
    21941192
    [PubMed - indexed for MEDLINE]
    16.

    Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.

    Guner R, Karahocagil M, Buyukberber M, Kandemir O, Ural O, Usluer G, Inan D, Koksal I, Baykam N, Hizel K, Yamazhan T, Esen S, Tasyaran MA.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1185-91.

    PMID:
    21934508
    [PubMed - indexed for MEDLINE]
    17.

    Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.

    Floreani A, Cazzagon N, Boemo DG, Baldovin T, Baldo V, Egoue J, Antoniazzi S, Minola E.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):997-1003.

    PMID:
    21915057
    [PubMed - indexed for MEDLINE]
    18.

    Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe.

    Urbanek P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Husa P.

    Eur J Gastroenterol Hepatol. 2011 Nov;23(11):1004-10.

    PMID:
    21904204
    [PubMed - indexed for MEDLINE]
    19.

    Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.

    Tafarel JR, Tolentino LH, Correa LM, Bonilha DR, Piauilino P, Martins FP, Rodrigues RA, Nakao FS, Libera ED, Ferrari AP, da Silveira Röhr MR.

    Eur J Gastroenterol Hepatol. 2011 Sep;23(9):754-8.

    PMID:
    21691209
    [PubMed - indexed for MEDLINE]
    20.

    Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy.

    Mariño Z, Carrión JA, Bedini JL, Crespo G, Martínez SM, Sánchez-Tapias JM, Forns X, Navasa MA.

    Eur J Gastroenterol Hepatol. 2011 Oct;23(10):942-7.

    PMID:
    21772147
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk